肺癌诊断中的肺脏病学进展:过去二十年的变革
本文由国际专家组综述了过去二十年肺脏病学在肺癌检测、诊断和管理方面的主要进展。内容涵盖筛查项目、支气管镜微创诊断与分期、腔内治疗与导航支气管镜、恶性胸腔积液管理及生物标志物风险分层。文章强调多学科团队对提供高质量循证诊疗的必要性,并分两部分讨论基本标准与新兴创新。
要点
- 支气管镜微创技术推动了肺癌诊断与分期。
- 导航支气管镜与腔内治疗使早期肺癌一步式诊疗成为可能。
- 多学科团队是高质量循证肺癌诊疗的核心。
核心结论
- 过去二十年肺脏病学在肺癌检测、诊断与管理方面的进展对肺癌诊疗和临床结局产生了变革性影响。
研究设计与样本
- 国际专家组综述过去二十年肺脏病学在肺癌诊断领域的主要进展,分基本标准与新兴创新两部分阐述。
主要发现
- 对肺癌流行病学和危险因素的认识改善为全球筛查项目提供了依据。
- 支气管镜的改进促成了肺癌微创诊断与分期技术。
- 腔内治疗技术进步结合导航支气管镜改进,使早期肺癌一步式诊断-分期-治疗成为可能。
- 恶性胸腔积液评估与管理的进步改善了临床结局和生活质量。
- 对肺癌发病机制的深入理解识别出可用于风险分层、靶向治疗应用、治疗相关副作用和复发可能性的生物标志物。
临床怎么用
- 肺癌诊疗的亚专业化发展结合快速技术与临床进展,使多学科团队成为提供高质量循证诊疗的必要方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pulmonologists have contributed significantly to the detection, diagnosis, and management of lung cancer in the past two decades. Improved understanding of lung cancer epidemiology and risk factors has informed screening programs across the world. Refinements in bronchoscopy have allowed the development of minimally invasive techniques for diagnosis and staging of lung cancer. Technological advances in endoluminal treatments for lung cancer coupled with refinements in navigational bronchoscopy raise the possibility of a one-step diagnosis-staging-treatment for early stage lung cancer. Advances in evaluation and management of malignant pleural effusions have led to better clinical outcomes and quality of life. Better understanding of lung cancer pathogenesis has identified biomarkers that inform cancer risk stratification, application of targeted therapies, treatment-related side effects, and likelihood of recurrence. The growing subspecialization of lung cancer care, coupled with rapid technological and clinical developments, has made essential the multidisciplinary team approach for delivering high-quality, evidence-based care. In this article, an international panel of experts will review the major developments in pulmonary diagnostics in lung cancer in the past two decades. Together, these developments have had a transformative effect on lung cancer care and clinical outcomes. The clinical impact of these developments will be explored, along with future potential for research and innovation, and presented in two parts, first for essential standards and second for emerging innovations.
引用
- Stone E, Hu X, Afriyie-Mensah JS, et al. Advances in Diagnosis-Pulmonology. J Thorac Oncol. 2026. PMID: 42250919. doi:10.1016/j.jtho.2026.103648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。